Double-blind randomized study of 1 g versus 2 g intravenous ceftriaxone daily in the therapy of community-acquired infections

S. Segev*, R. Raz, E. Rubinstein, H. Shmuely, D. Hassin, N. Rosen, E. Platau, S. Ben Assuli, S. Pitlik

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Double-blind randomized study of 1 g versus 2 g intravenous ceftriaxone daily in the therapy of community-acquired infections'. Together they form a unique fingerprint.

Medicine & Life Sciences